Table 4.

Clinical response and intrinsic subtype data for patient population

Chemo-prediction validation study
CharacteristicN (%)
Total cases216 (100)
Assay passed207 (95.8)
 Clinical data available180
CR
 RCB-0/I (responder)34 (18.9)
 RCB-II+ (nonresponder)146 (81.1)
 Luminal A54 (30)
  Nonresponder49 (90.7)
  Responder5 (9.3)
 Luminal B105 (58.3)
  Nonresponder84 (80.0)
  Responder21 (20.0)
 HER2-enriched7 (3.9)
  Nonresponder6 (85.7)
  Responder1 (14.3)
 Basal14 (7.8)
  Nonresponder7 (50)
  Responder7 (50)